(Q34987161)

5 August 2017

1 reference

title

Production methods for gene transfer vectors based on adeno-associated virus serotypes (English)

1 reference

5 August 2017

0 references

Dirk Grimm

1 reference

5 August 2017

publication date

1 October 2002

1 reference

5 August 2017

1 reference

5 August 2017

1 reference

5 August 2017

1 reference

5 August 2017

page(s)

146-157

1 reference

Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV).

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Adeno-associated virus vectors for gene therapy: more pros than cons?

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Cloning of infectious adeno-associated virus genomes in bacterial plasmids

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Novel tools for production and purification of recombinant adenoassociated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Role for highly regulated rep gene expression in adeno-associated virus vector production

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Adeno-associated virus vectors can be efficiently produced without helper virus

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Factors influencing recombinant adeno-associated virus production

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Quantitative analysis of the packaging capacity of recombinant adeno-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Production of high-titer helper-free retroviruses by transient transfection

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

A single-step affinity column for purification of serotype-5 based adeno-associated viral vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1046-2023%2802%2900219-0

7 January 2021

10.1016/S1046-2023(02)00219-0

Identifiers

DOI

1 reference

release_i57jpxqnrbdqpdyw6gau5vl2ji

5 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/i57jpxqnrbdqpdyw6gau5vl2ji

24 November 2022

mapped directly with Wikidata item

1 reference